Supratentorial grade II astrocytoma: biological features and clinical course (Q35172239)

6 August 2017

1 reference

title

Supratentorial grade II astrocytoma: biological features and clinical course (English)

1 reference

6 August 2017

1 reference

Peter H Wessels

1

1 reference

6 August 2017

Wim E J Weber

2

1 reference

6 August 2017

Guy Raven

3

1 reference

6 August 2017

Frans C S Ramaekers

4

1 reference

6 August 2017

Anton H N Hopman

5

1 reference

6 August 2017

Albert Twijnstra

6

1 reference

6 August 2017

publication date

1 July 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

2

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

395-403

1 reference

Incidence of primary central nervous system cancers in South and East Netherlands in 1989-1994.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Radiation therapy in the management of low-grade supratentorial astrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Hereditary tumor syndromes of the nervous system: overview and rare syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

A Report on Radiation-Induced Gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Epidemiology of primary CNS neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Cellular-telephone use and brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Descriptive epidemiology of cerebral gliomas in France.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas. A new pattern of prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Supratentorial low-grade astrocytomas in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Prognostic significance of contrast enhancement in low-grade astrocytomas of the adult cerebrum.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

How often are nonenhancing supratentorial gliomas malignant? A population study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Low grade glioma of the cerebral hemispheres in adults: a retrospective analysis of 88 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Treatment and survival of low-grade astrocytoma in adults--1977-1988

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Supratentorial low-grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

The management of histologically unverified presumed cerebral gliomas with radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Low grade supratentorial astrocytomas. Management and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Prognostic factors in low-grade supratentorial astrocytomas: a uni-multivariate statistical analysis in 76 surgically treated adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Radiation therapy with or without surgery in the management of low-grade brain astrocytomas. A retrospective study of 120 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Low-grade pure and mixed cerebral astrocytomas treated in the CT scan era.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

5-year survival and clinical prognostic factors in progressive supratentorial diffuse "low-grade" astrocytoma: a retrospective analysis of 46 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Clinical outcome of supratentorial astrocytoma WHO grade II.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Adult brain low-grade astrocytomas: survival after surgery and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group stud

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Prognostic factors for survival in adult patients with cerebral low-grade glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Low-grade astrocytomas may arise from different astrocyte lineages.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Limbic and neocortical gliomas associated with intractable seizures: a distinct clinicopathological group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Effect of age on treatment decisions in low-grade glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Phase II trial of temozolomide in patients with progressive low-grade glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Current and future developments in the use of temozolomide for the treatment of brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Suspected low-grade glioma: is deferring treatment safe?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Grading of astrocytomas. A simple and reproducible method.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Gemistocytic astrocytomas: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Protoplasmic astrocytoma. A clinicopathologic study of 16 tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Correlates of survival and the Daumas-Duport grading system for astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

The new WHO classification of brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Cellular proliferation in pilocytic and diffuse astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Intratumoral histologic heterogeneity of gliomas. A quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Successful chemotherapy for recurrent malignant oligodendroglioma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

MIB-1 proliferation index predicts survival among patients with grade II astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Proliferative activity and prognosis of low-grade astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Proliferative potential and prognostic evaluation of low-grade astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Chromosomal patterns in human malignant astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Interphase cytogenetics of brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Comparative genomic hybridization: practical guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Non-isotopic molecular cytogenetics in neuro-oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Progression as exemplified by human astrocytic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

The molecular and genetic basis of neurological tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Amplified cellular oncogenes in neoplasms of the human central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Proliferation of human malignant astrocytomas is dependent on Ras activation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Numerical aberrations of chromosomes 1, 2, and 7 in astrocytomas studied by interphase cytogenetics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Interphase cytogenetic (in situ hybridization) analysis of astrocytomas using archival, formalin-fixed, paraffin-embedded tissue and nonfluorescent light microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Grade II astrocytomas are subgrouped by chromosome aberrations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Amplification of Epidermal Growth Factor Receptor Gene in Gliomas: Histopathology and Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Loss of heterozygosity on chromosome 19 in secondary glioblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Prognostic implications of p53 overexpression in supratentorial astrocytic tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

TP53 alterations and clinical outcome in low grade astrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Differentiation between reactive gliosis and diffuse astrocytoma by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Identification of subgroups of high-grade oligodendroglial tumors by comparative genomic hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

Proliferation and aneusomy predict survival of young patients with astrocytoma grade II.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900434-4

7 January 2021

10.1016/S1474-4422(03)00434-4

Identifiers

DOI

1 reference

6 August 2017

1 reference